ScholarsBetaWeill Cornell Medicine

MG

Marc Goldstein, MD

Matthew P. Hardy, PhD Distinguished Professor of Reproductive Medicine and Urology

Contact & profiles

Appointments

Professor of UrologyPrimary
Urology · 1994–
Matthew P. Hardy, PhD Distinguished Professor of Reproductive Medicine and Urology
Urology · 2008–
Professor of Reproductive Medicine
Reproductive Medicine · 1999–
Physician
NewYork-Presbyterian Hospital

Past Appointments

Director of the Men's Center in Reproductive Medicine
Reproductive Medicine · 1999–2007
Co-Executive Director of the Institute of Reproductive Medicine
Reproductive Medicine · 1999–2007
Associate Professor of Urology
Urology · 1993–1994

Show all 6

Associate Professor of Surgery (Urology)
Surgery · 1988–1993
Assistant Professor of Surgery (Urology)
Surgery · 1982–1988
Adjunct Assistant Professor of Urology
Urology · 1982–1982

Centers

Clinical & Translational Science Center

Education

M.D.
State University of New York Health Science Center at Brooklyn, 1972
B.S.
Brooklyn College, City University of New York, 1968

Overview

View Dr. Goldstein's Video Introduction here

Highlights

1
The world journal of men's health · 2022
GWGal Wald MGMarc Goldstein
PMID: 35791300PMCID: PMC10042654DOISenior author15 citations
2
Urology practice · 2021
MGMarc Goldstein
PMID: 37145658DOISenior author7 citations
3
Urology practice · 2020
MGMarc Goldstein
PMID: 37145437DOISenior author11 citations

Publications

270

Funding

4 View NIH portfolio on RePORTER ↗

Active

1 grant

Co-I
A Training Infrastructure to Support Voluntary Male Circumcision in sub-Saharan Africa
Bill & Melinda Gates Foundation · 2019–2027
INV-003436

Completed grants (3)

KP
Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision in Sub-Saharan Africa
Bill & Melinda Gates Foundation · 2016–2023
OPP1158451
MPI
Video Microsurgery in Urology
Olympus Corp. · 2018–2019Equipment
MTA 191789-01
KP
Acceptability and Safety of Shang Ring Circumcision
National Institute of Allergy and Infectious Diseases · 2010–2012 · via The Johns Hopkins University
U01AI075115-05EWO

News mentions

1 View all WCM news ↗

ShangRing Circumcision Device Could Boost HIV Prevention Efforts
September 13, 2022
An easy-to-use device for infant circumcision has proved to be safe in an international randomized controlled clinical trial led by Weill Cornell Medicine physician-scientists. The results suggest that the device could boost efforts to increase circumcision rates and prevent HIV in low-resource settings where early infant circumcision is not widespread.

Mentoring

1

HP
Hudson Pierce
MD mentee · Class of 2019

External relationships

Advisory/Scientific Board Member

Theralogix